Trial of Zolpidem for Sleep in Children with Autism
Trial ID or NCT#
Status
Purpose
The purpose of this study is to examine the effect of zolpidem on sleep in children and adolescents with Autism Spectrum Disorder (ASD). Zolpidem is a nonbenzodiazepine GABAa receptor agonist drug that acts as a hypnotic. To accomplish this, the investigators will use a randomized double-blind placebo-controlled crossover 8-week study design to examine the effect of zolpidem on sleep physiology as assessed by polysomnography (PSG), actigraphy, circadian rhythm, and clinical measures.
Official Title
Randomized Placebo-Controlled Crossover Trial of Zolpidem for Sleep in Children with Autism
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Emma Baker, PhD
(650) 736-1235
View on ClinicalTrials.gov